so, that is a hersa oversight. and it is a hersa enforcement issues. i think the hospitals need to work with hersa to resolve that issue. that should not be happening in accordance with their updated guidance. >> okay. many wisconsin 340b hospitals have also told me about numerous audits that they experience. not only from their own internal, rigorous self auditing. but, also from hersa audits as well as audits by the drug companies. your agencies have recommended increasing oversight of drug manufacturers, including increasing audits, transparency, as well as the dispute resolution process. for covered entities to better obtain information from manufacturers. i am concerned that this uneven playing field between hospitals and drug companies continues to persist. bringing haas -- burning hospitals in the program. dr. draper and ms. maxwell, can you explain why your agencies recommended enhanced drug manufacturer oversight, such as audits, and what gaps remain that the administration has failed to address? >> with respect to our work, the gaps that rema